No evidence of decrease in cognitive function in users of low-dose Ecstasy.
Krebs
Teri S
TS
Johansen
Pål-Ørjan
PØ
D019969:Amphetamine-Related Disorders / Q000523:psychology*; D003071:Cognition / Q000187:drug effects*; D015331:Cohort Studies; D004305:Dose-Response Relationship, Drug; D005500:Follow-Up Studies; D006213:Hallucinogens / Q000008:administration & dosage / Q000633:toxicity*; D011939:Mental Recall / Q000187:drug effects; D018817:N-Methyl-3,4-methylenedioxyamphetamine / Q000008:administration & dosage / Q000633:toxicity*; D009483:Neuropsychological Tests; D011446:Prospective Studies; D012153:Retention, Psychology / Q000187:drug effects; D014706:Verbal Learning / Q000187:drug effects
D006213:Hallucinogens; D018817:N-Methyl-3,4-methylenedioxyamphetamine